VRDN SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0001104659-26-097208
VRDN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. An institutional holder filed an amended Schedule 13G for Viridian Therapeutics, indicating a change in its passive ownership position. The stock moved +0.4% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G for Viridian Therapeutics, indicating a change in its passive ownership position. No specific ownership percentage or share count is disclosed in the filing text provided.
Key details
How VRDN stock reacted
Close before
$21.99
Aug 13, 2026
First close after
+0.41%
$22.08
5 trading days
+11.41%
$24.50
Since filing
+29.56%
$28.49
✦ Ask GOAX AI about this filing — what it means for VRDN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VRDN?
Click hereFrequently asked questions
What did VRDN file with the SEC on Aug 14, 2026?
VRDN filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for Viridian Therapeutics, indicating a change in its passive ownership position. No specific ownership percentage or share count is disclosed in the filing text provided.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did VRDN stock react to this filing?
VRDN closed at $21.99 before the filing and $22.08 on Aug 14, 2026 (+0.41%). Five trading days later: $24.50 (+11.41%).
Other VRDN SEC filings
- 10-Q · SEC filingNov 4, 2026
- 8-K · SEC filingNov 4, 2026
- SCHEDULE 13G · SEC filingAug 20, 2026
- SCHEDULE 13G · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · Material agreementAug 6, 2026
- 8-K · Guidance raiseAug 6, 2026
- 8-K · Fda approvalJun 29, 2026
- 8-K · Board changeJun 3, 2026
Get alerts when VRDN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days